An International, Phase 2, Open-Label, Randomized Study of BGB-3111 Combined with Obinutuzumab Compared with Obinutuzumab Monotherapy in Relapsed/Refractory Follicular Lymphoma
- Opat, Stephen (Primary Chief Investigator (PCI))
Project: Research
Project: Research